Embolx, out of Silicon Valley, won the European CE Mark for its latest Sniper Balloon Occlusion Microcatheters. The devices are used to help deliver embolic agents in such varying procedures as helping to treat tumors, uterine fibroids, and enlarged prostate. The new family of the devices include features to make them easier to navigate through small vascular structures. They were recently cleared in the United States.
Often, the blood flow near a site that you want to deliver drugs to is so overwhelming, that drugs don’t have much chance to settle in and penetrate a tumor or some other object. The basic idea of Sniper microcatheters is that their balloon is used to block some of the blood flow near where you want to deliver the drug. The blockage creates a change in the local hemodynamics that sends the agents toward their intended target.
Here’s an intuitive look at how the Embolx technology works:
Flashback: Embolx Announces FDA Clearance for Next Generation Sniper Balloon Occlusion Microcatheter…
Product page: Sniper Balloon Occlusion Microcatheter…
Via: Embolx…
